Your browser doesn't support javascript.
loading
The hematologic profile of Filipino HIV-infected individuals and its association with CD4 counts
Vaswani, Preeti Prerna M; Senga-Tang, Issa Rufina; Catapia, Jean Rachel M; Abad, Cybele Lara R; Dumagay, Teresita E.
  • Vaswani, Preeti Prerna M; University of the Philippines. Philippine General Hospital. Department of Medicine. Manila. PH
  • Senga-Tang, Issa Rufina; University of the Philippines. Philippine General Hospital. Department of Medicine. Manila. PH
  • Catapia, Jean Rachel M; University of the Philippines. Philippine General Hospital. Department of Medicine. Manila. PH
  • Abad, Cybele Lara R; University of the Philippines. Philippine General Hospital. Department of Medicine. Manila. PH
  • Dumagay, Teresita E; University of the Philippines. Philippine General Hospital. Department of Medicine. Manila. PH
Hematol., Transfus. Cell Ther. (Impr.) ; 44(3): 307-313, July-Sept. 2022. tab
Article in English | LILACS | ID: biblio-1404986
ABSTRACT
ABSTRACT

Introduction:

Hematologic abnormalities are common in HIV and involve all blood cell lineages. A study on cytopenias, as correlated with disease progression, can be valuable in resource-limited settings. This study aimed to determine the hematologic profile of HIV patients and its association with CD4 count and antiretroviral (ARV) treatment.

Methods:

This is a retrospective cohort study involving adult Filipino HIV patients with complete blood count (CBC) and CD4 count determinations prior to the initiation of ARV treatment and after ≥6 months of ARV treatment. Logistic regression was performed to determine the association between cytopenias and a CD4 count <200 cells/μL.

Results:

The study included 302 patients. Anemia was the most common cytopenia. Anemia and leukopenia were associated with an increased likelihood of having a CD4 count <200 cells/μL in ARV-naïve patients. In ARV-treated patients, leukopenia was associated with an increased probability of having a CD4 count <200 cells/μL. An increase in hemoglobin, white blood cell (WBC) and platelet counts was observed after ≥6 months of ARV treatment.

Conclusion:

Anemia and leukopenia can be used as markers of immune status in HIV-infected individuals and improvement in the CBC parameters can be used to assess response to ARV treatment. Routine monitoring of hematologic parameters is recommended.
Subject(s)


Full text: Available Index: LILACS (Americas) Main subject: HIV Infections / Antiretroviral Therapy, Highly Active / Leukopenia Type of study: Observational study / Risk factors Limits: Adult / Aged / Aged80 / Female / Humans / Male Language: English Journal: Hematol., Transfus. Cell Ther. (Impr.) Journal subject: Hematologia / TransfusÆo de Sangue Year: 2022 Type: Article Affiliation country: Philippines Institution/Affiliation country: University of the Philippines/PH

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Index: LILACS (Americas) Main subject: HIV Infections / Antiretroviral Therapy, Highly Active / Leukopenia Type of study: Observational study / Risk factors Limits: Adult / Aged / Aged80 / Female / Humans / Male Language: English Journal: Hematol., Transfus. Cell Ther. (Impr.) Journal subject: Hematologia / TransfusÆo de Sangue Year: 2022 Type: Article Affiliation country: Philippines Institution/Affiliation country: University of the Philippines/PH